HighTower Advisors LLC Invests $1.40 Million in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• HighTower Advisors LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences, purchasing 136,989 shares valued at approximately $1.4 million.
• Oaktree Acquisition Corp. III Life Sciences' stock price is currently $10.43, reflecting a 52-week range of $9.95 to $10.85.
• Several other institutional investors also made significant investments in OACC during the fourth quarter, totaling over $40 million in combined purchases.

HighTower Advisors LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 136,989 shares of the company's stock, valued at approximately $1,401,000. HighTower Advisors LLC owned 0.61% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Picton Mahoney Asset Management acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $767,000. K2 Principal Fund L.P. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $1,945,000. Mizuho Securities USA LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $2,020,000. Sculptor Capital LP acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $2,490,000. Finally, TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $2,988,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of NASDAQ OACC traded down $0.01 during mid-day trading on Thursday, reaching $10.44. The company had a trading volume of 59,269 shares, compared to its average volume of 79,940. The stock has a fifty day moving average of $10.45 and a two-hundred day moving average of $10.33. Oaktree Acquisition Corp. III Life Sciences has a 12-month low of $9.95 and a 12-month high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.